Roger G. Stoll Ph.D., Director at Chelsea Therapeutics International, Ltd. (CHTP), bought 5,000 shares at $4.86 ($24K) on 2008-09-08, disclosed to the SEC on 2008-09-10.
Open-market purchase of $24k CHTP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| DCTH | BUY | 2015-07-28 | $11K | — | Filing → |
| DCTH | BUY | 2009-11-20 | $90K | — | Filing → |
| DCTH | BUY | 2009-08-26 | $31K | — | Filing → |